FIELD: medicine.
SUBSTANCE: invention relates to the use of a complex of a compound with metal for the treatment of tumors with integrin expression, wherein the specified compound is 2,2', 2''-(10-(2-(((R)-1-((2-(4-(4-(N-((S)-1-carboxy-2-(5-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)pentanamide)ethyl)sulfamoyl)-3,5-dimethylmethoxy)butanamide)ethyl)amino)-1-oxo-3-sulfopropan-2-yl)amino)-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetic acid and the specified metal is Lu.
EFFECT: providing the treatment of tumors with integrin expression.
2 cl, 6 dwg, 7 tbl, 17 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING A NOVEL NITROGEN-CONTAINING COMPOUND OR A SALT THEREOF AND PRODUCING AN INTERMEDIATE THEREOF | 2016 |
|
RU2720989C2 |
AVB6 INTEGRIN INHIBITORS | 2018 |
|
RU2769702C2 |
ANTAGONISTS OF SOMATOSTATIN RECEPTOR SUBTYPE 5 (SSTR5) | 2014 |
|
RU2671958C2 |
CONDENSED HETEROCYCLIC NITROGEN COMPOUNDS AND USING THEM AS INHIBITORS OF AMYLOID BETA PRODUCTION | 2010 |
|
RU2515976C2 |
NITROIMIDAZOLE DERIVATIVE AGAINST PULMONARY TUBERCULOSIS | 2016 |
|
RU2675622C1 |
HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2015 |
|
RU2711502C2 |
TRICYCLIC COMPOUND AND JAK INHIBITOR | 2015 |
|
RU2674262C2 |
THIOPHENYL AND PYRROLYL AZEPINES AS SEROTONIN 5HT RECEPTOR LIGANDS AND USE THEREOF | 2007 |
|
RU2434872C2 |
CONDENSED AMINOHYDROTHIAZINE DERIVATIVE | 2009 |
|
RU2476431C2 |
RESORCINOL DERIVATIVE AS HSP90 INHIBITOR | 2016 |
|
RU2697703C2 |
Authors
Dates
2022-03-17—Published
2016-03-25—Filed